Relay Therapeutics Inc
Ownership
Ownership Structure
Who owns Relay Therapeutics Inc (RLAY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 66.4% of the shares are freely tradable; institutional investors hold 87.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 12.73 | 27,904,963 | +0.0 | 06/30/2026 |
| FMR Inc | 9.18 | 20,110,113 | +444.2 | 06/30/2026 |
| Casdin Capital, LLC | 7.32 | 16,035,240 | +11.2 | 06/30/2026 |
| BlackRock Inc | 6.98 | 15,288,202 | +17.8 | 06/30/2026 |
| Perceptive Advisors LLC | 6.44 | 14,106,187 | +44.7 | 06/30/2026 |
| COMMODORE CAPITAL LP | 5.48 | 12,000,000 | -29.4 | 06/30/2026 |
| State Street Corp | 4.62 | 10,125,381 | +62.4 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.09 | 8,964,423 | +21.3 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 3.52 | 7,708,507 | +300.5 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.12 | 6,838,289 | +0.3 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| SVF Pauling (Cayman) Ltd | 10% Owner | 21,904,963 | 403,051,319 $ | Aug 25, 2026 | indirect |
| Patel Sanjiv | President and CEO | 471,301 | 8,671,938 $ | Oct 7, 2026 | direct |
| Bergstrom Donald A | President, R&D | 396,878 | 7,302,555 $ | Oct 28, 2026 | direct |
| Rahmer Peter | See remarks | 222,904 | 4,101,434 $ | Oct 28, 2026 | direct |
| Catinazzo Thomas | Chief Financial Officer | 103,665 | 1,907,436 $ | Oct 28, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Rahmer Peter | See remarks | Sell | 753 | 18.62 | 14,021 |
| Oct 28, 2026 | Bergstrom Donald A | President, R&D | Sell | 2,252 | 18.62 | 41,932 |
| Oct 28, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 1,469 | 18.62 | 27,353 |
| Oct 7, 2026 | Patel Sanjiv | President and CEO | Sell | 48,199 | 18.10 | 872,402 |
| Oct 6, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 206 | 19.26 | 3,968 |
| Oct 6, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,511 | 18.58 | 325,354 |
| Sep 8, 2026 | Bergstrom Donald A | President, R&D | Sell | 8,530 | 18.97 | 161,814 |
| Sep 8, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | 18.94 | 335,560 |
| Sep 8, 2026 | Patel Sanjiv | President and CEO | Sell | 48,199 | 18.94 | 912,889 |
| Aug 26, 2026 | Rahmer Peter | See remarks | Sell | 4,508 | 20.03 | 90,295 |
| Aug 25, 2026 | SVF Pauling (Cayman) Ltd | 10% Owner | Sell | 6,000,000 | 19.40 | 116,400,000 |
| Aug 17, 2026 | Patel Sanjiv | President and CEO | Sell | 48,199 | 20.33 | 979,886 |
| Aug 14, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | 19.74 | 349,734 |
| Jul 28, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 1,459 | 18.61 | 27,152 |
| Jul 28, 2026 | Rahmer Peter | See remarks | Sell | 748 | 18.61 | 13,920 |
| Jul 28, 2026 | Bergstrom Donald A | President, R&D | Sell | 2,237 | 18.61 | 41,631 |
| Jul 7, 2026 | Patel Sanjiv | President and CEO | Sell | 48,199 | 19.58 | 943,736 |
| Jul 6, 2026 | Bergstrom Donald A | President, R&D | Sell | 8,660 | 18.71 | 162,029 |
| Jul 6, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | 18.69 | 331,131 |
| Jun 30, 2026 | Patel Sanjiv | President and CEO | Other | 3,056 | 6.95 | 21,239 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.